123 completed, 63 recruiting, 45 unknown, 25 not yet recruiting. 312 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 312 | Completed 123, Recruiting 63, Unknown 45, Not yet recruiting 25, Active not recruiting 20, Terminated 20, Withdrawn 15, Enrolling by invitation 1 |
Follow Hematologic Neoplasms: new trials by email Literature Review of Hematologic Neoplasms trials Research Report on Hematologic Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Symptom Monitoring and Management Intervention After CAR-T WAYPOINT - Chimeric Antigen Receptor T-cell Therapy, Hematologic Malignancy | Not applicable | Not yet recruiting | Massachusetts General Hospital | 65 | 2027-03-01 | 2026-10-23 |
| WELL-MPN: A Digital Lifestyle App for Patients With MPNs WELL-MPN Digital App - Myeloproliferative Neoplasms (MPNs) | Not applicable | Not yet recruiting | Brigham and Women's Hospital | 75 | 2027-01-01 | 2026-09-29 |
| Study to Characterize Mismatched to Fully HLA-Matched Ossium HPC, Marrow and Living Donor Transplantation in Patients With Hematologic Malignancies Ossium HPC, Marrow, Standard of care living donor - Haplo Related, Standard of care living donor - Mismatched Unrelated - Hematologic Malignancy, Acute Leukemia | Not applicable | Not yet recruiting | Ossium Health, Inc. | 300 | 2026-12-01 | 2026-09-10 |
| Micro Assays for HemATology Malignancies Antibody Treatment blood sampling - Hematological Malignancy | Not applicable | Not yet recruiting | Assistance Publique Hopitaux De Marseille | 166 | 2026-12-01 | 2026-10-29 |
| Virtual Reality Intervention to Improve Comfort in Hospitalized Hematology Patients Immersive virtual reality experience - Hematologic Cancer | Not applicable | Recruiting | Fundación para la Investigación del Hospital Clínico de Valencia | 145 | 2026-10-26 | 2026-11-02 |
| Effects of Resistance Training on Recovery During Hematopoietic Stem Cell Transplantation 8-week Elastic Band Resistance Training Program - Hematologic Malignancies, Hematopoietic Stem Cell Transplantation | Not applicable | Not yet recruiting | Taipei Veterans General Hospital, Taiwan | 86 | 2026-10-12 | 2026-10-14 |
| Effects of Synbiotic Supplementation on Gastrointestinal Symptoms, Appetite, and Nutritional Recovery in Patients After Autologous Bone Marrow Transplant Tri-component Synbiotic Supplement - Hematologic Neoplasms, Gastrointestinal Symptoms | Not applicable | Not yet recruiting | Alexandria University | 40 | 2026-10-01 | 2026-10-01 |
| Standardized Documentation and Assessments for Polycythemia Vera: A Quality Improvement Initiative Standardized progress note - Polycythemia Vera | Not applicable | Recruiting | Massachusetts General Hospital | 32 | 2026-09-11 | 2026-11-13 |
| Immunological Impact of a Post Cell Therapy Treatment With FLT3 Inhibitors Gilteritinib - Hematological Malignancies | Not applicable | Not yet recruiting | Centre Hospitalier Universitaire de Nice | 10 | 2026-09-01 | 2026-06-22 |
| Comprehensive Palliative Care After Stem Cell Transplantation: a Feasability Study Early Integrated Palliative Care - Hematopoietic Stem Cell Transplantation (HSCT) | Not applicable | Recruiting | Lisa Hentsch | 42 | 2026-08-27 | 2026-10-26 |
| M-2018-334 in Hematological Malignancies CliniMACS Prodigy® LP-TCRα/β-19-45RA (Trial Version) - Hematological Malignancies | Not applicable | Recruiting | Miltenyi Biomedicine GmbH | 18 | 2026-08-21 | 2026-09-11 |
| ENERGIA: Personalized Exercise Program for Fatigue in Patients With Myeloproliferative Neoplasms and Chronic Myeloid Leukemia Participants will take part in a 12-week exercise program that includes aerobic and resistance training, tailored to their individual fitness level and clinical condition. - Myeloproliferative Disease, Polycythemia Vera | Not applicable | Not yet recruiting | Carmen Fava | 25 | 2026-08-01 | 2026-04-09 |
| Digitalized Exercise Fit Tool Intervention for Adolescents With Blood Cancer Digitalized Exercise Fit Tool Intervention, Usual Care - Hematologic Cancer, Leukaemia | Not applicable | Not yet recruiting | The Hong Kong Polytechnic University | 30 | 2026-07-20 | 2026-07-27 |
| Robotic Dog Intervention on Emotional Well-Being and Quality of Life AIBO - Emotional Well-being, Quality of Life | Not applicable | Not yet recruiting | Koç University | 28 | 2026-07-01 | 2026-05-26 |
| Take5Care+: A Self-management Educational Intervention Take5Care+ - Hematologic Neoplasms | Not applicable | Not yet recruiting | Jitka Vseteckova | 20 | 2026-07-01 | 2026-06-29 |
| Complementary and Alternative Medicine Among Patients With Hematologic Malignancies in France Questionnaire on Complementary and Alternative Medicines (CAM) - Hematological Malignancies | Not applicable | Not yet recruiting | University Hospital, Limoges | 85 | 2026-06-15 | 2026-04-21 |
| HematoCare: Feasibility of a Survivorship Care Plan for Hematologic Cancer Patients Undergoing HSCT Survivorship Care (SC) Plan - Hematologic Neoplasm, Hematopoietic Stem Cell Transplantation | Not applicable | Recruiting | Azienda USL Reggio Emilia - IRCCS | 40 | 2026-06-01 | 2026-07-24 |
| Evaluation of Safety and Efficacy of Autologous LB-DTK-CMV in Patients With Antiviral-Resistant and Refractory Cytomegalovirus Retinitis. LB-DTK-CMV - CMV Retinitis | Not applicable | Recruiting | LucasBio | 5 | 2026-04-27 | 2026-07-01 |
| The Efficacy and Safety of Stereotactic Radiotherapy Bridging Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of Hematological Malignance Patients With Extramedullary Infiltrating Stereotactic body radiotherapy (SBRT) - HSCT, Hematologic Cancer | Not applicable | Not yet recruiting | Institute of Hematology & Blood Diseases Hospital, China | 20 | 2026-04-14 | 2026-03-06 |
| Assessing DCog Short for Neurotoxicity in CAR-T DCog Short - Neurotoxicity, Neurotoxicity Syndromes | Not applicable | Recruiting | Beth Israel Deaconess Medical Center | 40 | 2026-04-13 | 2026-10-08 |
Showing 20 of 312. Sign in to see all of them.
Leukemia (41) · Lymphoma (40) · Multiple Myeloma (38) · Neoplasms (38) · Polycythemia Vera (24) · Myelodysplastic Syndromes (22) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (22) · Leukemia, Myeloid, Acute (21) · Primary Myelofibrosis (20) · Leukemia, Lymphocytic, Chronic, B-Cell (19) · Myeloproliferative Disorders (19) · Hodgkin Disease (18) · Thrombocythemia, Essential (18) · Lymphoma, Large B-Cell, Diffuse (16)
Hemic and Lymphatic Diseases (312) · Neoplasms by Site (310) · Hematologic Diseases (299) · Neoplasms (274) · Immune System Diseases (74) · Neoplasms by Histologic Type (72) · Pathological Conditions, Signs and Symptoms (72) · Immunoproliferative Disorders (59) · Lymphatic Diseases (56) · Lymphoproliferative Disorders (54) · Bone Marrow Diseases (51) · Hemorrhagic Disorders (47) · Pathologic Processes (43) · Cardiovascular Diseases (40) · Vascular Diseases (39)
Standard of Care (10) · Exercise (9) · Educational Status (8) · Practice Guidelines as Topic (8) · Blood Specimen Collection (7) · Methods (7) · Peripheral Blood Stem Cell Transplantation (7) · fludarabine phosphate (7) · Cyclophosphamide (6) · Early Intervention, Educational (6) · Behavior Therapy (5) · Busulfan (5) · Interviews as Topic (5) · Palliative Care (5) · fludarabine (5)
Massachusetts General Hospital (13) · M.D. Anderson Cancer Center (12) · Duke University (10) · City of Hope Medical Center (9) · Fred Hutchinson Cancer Center (8) · Dana-Farber Cancer Institute (7) · Brigham and Women's Hospital (6) · University of California, San Francisco (6) · Mayo Clinic (5) · Ohio State University Comprehensive Cancer Center (5) · Wake Forest University Health Sciences (5) · Copenhagen University Hospital, Rigshospitalet (4) · Thomas Jefferson University (4) · University Health Network, Toronto (4) · Azienda USL Reggio Emilia - IRCCS (3)
United States (156) · France (32) · Canada (14) · China (14) · Italy (13) · Turkey (Türkiye) (11) · Denmark (7) · Germany (7) · Spain (5) · Australia (3) · Brazil (3) · Switzerland (3) · Chile (2) · Egypt (2) · Ireland (2)
Hermioni Amonoo, MD, MPP, MPH (4) · Areej El-Jawahri, MD (3) · Charles A. Linker, MD (2) · Chenyu Lin, MD (2) · Gary Rodin, MD FRCPC (2) · Jean S Edward, PhD, RN (2) · Kuang-Yueh Chiang, M.D. (2) · Nelson Chao, MD, MBA (2) · Patrick C Johnson, MD (2) · Tamara J Somers, PhD (2) · Ying Lu (2) · A. John Barrett, M.D. (1) · Abby R Rosenberg, MD, MS, MA (1) · Adam Binder, MD (1) · Adam Mueller, MD (1)
PMID 39606939, PMID 10091805, PMID 17008536, PMID 17573453, PMID 18322708, PMID 18619375, PMID 18698002, PMID 20953908, PMID 22050904, PMID 22147646, PMID 22461866, PMID 22776268, PMID 23046417, PMID 23065508, PMID 23358983, PMID 23485478, PMID 23524640, PMID 23954992, PMID 24125911, PMID 24179471, PMID 25040144, PMID 25299140, PMID 25386344, PMID 25445023, PMID 25728366, PMID 25753814, PMID 26061092, PMID 26169616, PMID 26345187, PMID 26451310, PMID 26473759, PMID 26699701, PMID 26719433, PMID 26822328, PMID 28042020, PMID 28061985, PMID 28253393, PMID 28458705, PMID 28621019, PMID 28670114, PMID 28688533, PMID 28915856, PMID 29171820, PMID 29313949, PMID 29336645, PMID 29506345, PMID 29599530, PMID 29626261, PMID 30165140, PMID 30191843
P30CA033572 (7), P30CA015704 (4), P30CA015083 (3), 2017 (1), 2018 (1), IK2RX003245-03 (1), K07CA222335 (1), K08CA245107 (1), K08CA251654 (1), K08CA273043 (1), K08CA273684 (1), K08CA279500 (1), K08CA283026 (1), K12CA167540 (1), P01CA018029 (1)